IRON 250117 65.00C (IRON250117C65000) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

IRON250117C65000

Watchlist

4.50
0.000.00%

15min DelayTrading Nov 26 10:21 ET

0.00High0.00Low

Intraday

5D
Daily

News

Disc Medicine Is Maintained at Buy by Stifel
Dow JonesDec 10 11:31 ET · Ratings
Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $90
Moomoo NewsDec 10 08:34 ET · Ratings
A Quick Look at Today's Ratings for Disc Medicine(IRON.US), With a Forecast Between $70 to $118
Moomoo NewsDec 10 08:00 ET · Ratings
Express News | Disc Medicine Inc : Stifel Raises Target Price to $90 From $79
ReutersDec 10 06:44 ET
Disc Medicine (IRON) Gets a Buy From Wells Fargo
TipRanksDec 10 04:47 ET · Ratings
Promising Pipeline Developments Bolster Buy Rating for Disc Medicine
TipRanksDec 10 01:05 ET · Ratings

Comments

Unusual Volume Ticks close to close. 4:42pm

$Kazia Therapeutics (KZIA.US)$ $Disc Medicine (IRON.US)$ $Air Transport Services (ATSG.US)$ $Globalstar (GSAT.US)$ $Tenaya Therapeutics (TNYA.US)$ $BIOSIG TECHNOLOGIES INC (BSGM.US)$ $Hanryu Holdings (HRYU.US)$ $Vast Renewables (VSTE.US)$ $Neurogene (NGNE.US)$ $Advent Technologies (ADN.US)$ $Staffing 360 Solutions (STAF.US)$ $Nuwellis (NUWE.US)$ $Simpple (SPPL.US)$
📊⚡️📊

Unusual Volume Ticks close to close. 4:42pm

2

3

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Biotech Stock Catalyst Watchlist 👀

Biotech Stock Catalyst Watchlist 👀

17

3

3

$Disc Medicine (IRON.US)$ easy money

2

Invest with Sarge

Not Ironman ...

Disc Medicine $Disc Medicine (IRON.US)$ down 55% on Monday.

Not Ironman ...

3

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...

Upcoming Ph 2 readouts in Q1 2024…

38

9

1

Read more